focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,801.00
Bid: 4,799.00
Ask: 4,802.00
Change: -82.00 (-1.68%)
Spread: 3.00 (0.063%)
Open: 4,886.00
High: 4,897.00
Low: 4,790.00
Prev. Close: 4,883.00
CRDA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Restatement of results for new reporting structure

4 Jun 2021 13:13

RNS Number : 9165A
Croda International PLC
04 June 2021
 

Regulatory News Announcement

4 June 2021

 

Croda International Plc

Restatement of results for new reporting structure

 

Croda International Plc ('Croda' or 'the Group') announced in November 2020 that from 2021 it would amend its reporting structure to report under four sectors - Consumer Care, Life Sciences, Performance Technologies and Industrial Chemicals.

 

In advance of its half year results on 27 July 2021, the Group is publishing restated segmental results for half year 2020 to provide a like-for-like comparator.

 

Consumer Care comprises the Personal Care sector, including Iberchem, a customer previously reported within Life Sciences, and the Home Care business unit from Performance Technologies.

 

The table below sets out the new structure, showing half year 2020 results as previously reported and the results for the same period restated to reflect the new structure. There is no impact from the Group's acquisitions of Avanti and Iberchem as they were both completed in the second half of 2020.

Sales

Adjusted operating profit*

Half year ended 30 June 2020

Reported currency

 

As

reported

£m

Restated

£m

As

reported

£m

Restated

£m

Consumer Care

226.7

251.1

68.9

73.7

Life Sciences

182.9

179.8

59.4

57.8

Performance Technologies

216.3

195.0

32.7

29.5

Industrial Chemicals

47.0

47.0

0.6

0.6

Group

672.9

672.9

161.6

161.6

 

* Adjusted operating profit is stated before exceptional items, acquisition costs and amortisation of intangible assets arising on acquisition.

 

Further information

 

David Bishop, Director of Investor Relations and Corporate Affairs: +44 7823 874428

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAAKLEENFEFA
Date   Source Headline
4th Nov 20148:33 amRNSDirector/PDMR Shareholding
21st Oct 20149:27 amRNSHolding(s) in Company
13th Oct 20145:26 pmRNSDirector/PDMR Shareholding
10th Oct 20147:00 amRNSDirectorate Change
2nd Oct 20142:43 pmRNSDirector/PDMR Shareholding
24th Sep 20145:48 pmRNSDirector/PDMR Shareholding
19th Sep 20144:00 pmRNSDirector/PDMR Shareholding
11th Sep 20143:02 pmRNSDirector/PDMR Shareholding
12th Aug 20143:20 pmRNSDirector/PDMR Shareholding
1st Aug 20149:23 amRNSDirector/PDMR Shareholding
24th Jul 201411:42 amRNSDirector/PDMR Shareholding
22nd Jul 201411:36 amRNSInterim Result 2014 - Replacement
22nd Jul 20147:00 amRNSInterim Results 2014
18th Jul 20149:21 amRNSHolding(s) in Company
14th Jul 20147:00 amRNSDirector/PDMR Shareholding
9th Jul 20149:39 amRNSHolding(s) in Company
30th Jun 20144:31 pmRNSDirector/PDMR Shareholding
30th Jun 201411:01 amRNSDirector/PDMR Shareholding
27th Jun 201410:33 amRNSDirector/PDMR Shareholding
26th Jun 201412:15 pmRNSHolding(s) in Company
24th Jun 20147:00 amRNSQ2 Pre-Close Trading Update
18th Jun 20147:00 amRNSSean Christie to step down as GFD in April 2015
11th Jun 20148:26 amRNSDirector/PDMR Shareholding
2nd Jun 20145:55 pmRNSDirector/PDMR Shareholding
29th May 20148:56 amRNSDirector/PDMR Shareholding
14th May 20149:22 amRNSDirector/PDMR Shareholding
13th May 20142:16 pmRNSDirector/PDMR Shareholding
8th May 201411:31 amRNSDirector/PDMR Shareholding
25th Apr 201410:45 amRNSHolding(s) in Company
24th Apr 20141:10 pmRNSResult of AGM
24th Apr 20147:00 amRNSInterim Management Statement
11th Apr 20144:51 pmRNSDirector/PDMR Shareholding
1st Apr 20147:01 amRNSDirector Declaration
31st Mar 20141:52 pmRNSDirector/PDMR Shareholding
27th Mar 20145:17 pmRNSDirector/PDMR Shareholding
24th Mar 20145:30 pmRNSAnnual Financial Report
12th Mar 20142:16 pmRNSDirector/PDMR Shareholding
7th Mar 20143:42 pmRNSDirector/PDMR Shareholding
6th Mar 20143:33 pmRNSDirector/PDMR Shareholding
3rd Mar 20142:52 pmRNSDirector/PDMR Shareholding
25th Feb 20147:00 amRNSPreliminary Results
24th Jan 20147:00 amRNSDirectorate Change
13th Jan 20143:15 pmRNSDirector/PDMR Shareholding
11th Dec 20132:32 pmRNSDirector/PDMR Shareholding
10th Dec 20134:25 pmRNSDirector/PDMR Shareholding
28th Nov 20131:35 pmRNSHolding(s) in Company
13th Nov 20131:41 pmRNSDirector/PDMR Shareholding
13th Nov 201310:07 amRNSHolding(s) in Company
8th Nov 20139:52 amRNSDirector/PDMR Shareholding
7th Nov 20132:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.